생물정신의학 (Korean Journal of Biological Psychiatry)

  • 제17권1호
  • /
  • Pages.5-14
  • /
  • 2010
  • /
  • 1225-8709(pISSN)
  • /
  • 2005-7571(eISSN)
대한생물정신의학회 (The Korean Society of Biological Psychiatry)
권호 표지

항우울제의 복약 순응도

Treatment Compliance of Antidepressants

  • 이문수 (고려대학교 의과대학 신경정신과학교실) ;
  • 고영훈 (고려대학교 의과대학 신경정신과학교실) ;
  • 조숙행 (고려대학교 의과대학 신경정신과학교실)
  • Lee, Moon-Soo (Department of Psychiatry, Korea University College of Medicine) ;
  • Ko, Young-Hoon (Department of Psychiatry, Korea University College of Medicine) ;
  • Joe, Sook-Haeng (Department of Psychiatry, Korea University College of Medicine)
  • 발행 : 2010.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Depressive disorder is a chronic disabling condition with recurrent episodes. Medication noncompliance is a significant problem for effective management of depressive disorder. However, compliance with antidepressant medication is poor. There are difficulties in assessing compliance accurately. Various methods for assessing compliance are in use. A patient's compliance with antidepressant may be affected by many factors including the clinical characteristics of depression, pharmacologic properties of antidepressants, patients' characteristics, accessibility treatment, and doctor-patient relationships. For enhancing the treatment compliance, psychotherapeutic considerations in patient-therapist relationship are needed.

키워드

참고문헌

  1. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. https://doi.org/10.1001/archpsyc.1994.03950010008002
  2. Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386-392 https://doi.org/10.1192/bjp.184.5.386
  3. Cho MJ, Kim JK, Jeon HJ, Suh T, Chung IW, Hong JP, et al. Lifetime and 12-month prevalence of DSMIV psychiatric disorders among Korean adults. J Nerv Ment Dis 2007;195:203-210. https://doi.org/10.1097/01.nmd.0000243826.40732.45
  4. Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet 2007;370:851-858. https://doi.org/10.1016/S0140-6736(07)61415-9
  5. Demyttenaere K. Compliance during treatment with antidepressants. J Affect Disord 1997;43:27-39. https://doi.org/10.1016/S0165-0327(96)00095-X
  6. Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L. Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 1992;149:795-800. https://doi.org/10.1176/ajp.149.6.795
  7. Melfi CA, Chawla AJ, Croghan TW, Hanna MP, Kennedy S, Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatry 1998;55:1128-1132. https://doi.org/10.1001/archpsyc.55.12.1128
  8. Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992;305:1198-1202. https://doi.org/10.1136/bmj.305.6863.1198
  9. Frank E, Kupfer DJ, Perel JM, Cornes C, Jarrett DB, Mallinger AG, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry 1990;47:1093-1099. https://doi.org/10.1001/archpsyc.1990.01810240013002
  10. Delgado PL. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry 2000;61:6-9.
  11. Colom F, Vieta E. Non-adherence in psychiatric disorders: misbehaviour or clinical feature? Acta Psychiatr Scand 2002;105:161-163. https://doi.org/10.1034/j.1600-0447.2002.1e003.x
  12. Katon W, von Korff M, Lin E, Bush T, Ormel J. Adequacy and duration of antidepressant treatment in primary care. Med Care 1992;30:67-76. https://doi.org/10.1097/00005650-199201000-00007
  13. Cramer JA, Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 1998;49:196-201. https://doi.org/10.1176/ps.49.2.196
  14. Simon GE, VonKorff M, Wagner EH, Barlow W. Patterns of antidepressant use in community practice. Gen Hosp Psychiatry 1993;15:399-408. https://doi.org/10.1016/0163-8343(93)90009-D
  15. Lin EH, Von Korff M, Katon W, Bush T, Simon GE, Walker E, et al. The role of the primary care physician in patients' adherence to antidepressant therapy. Med Care 1995;33:67-74. https://doi.org/10.1097/00005650-199501000-00006
  16. Olfson M, Marcus SC, Tedeschi M, Wan GJ. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 2006;163:101-108. https://doi.org/10.1176/appi.ajp.163.1.101
  17. Dunn RL, Donoghue JM, Ozminkowski RJ, Stephenson D, Hylan TR. Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. J Psychopharmacol 1999;13:136-143. https://doi.org/10.1177/026988119901300204
  18. Lee KU, Kim W, Min KJ, Shin YC, Chung SK, Bahk WM. The rate and risk factors of early discontinuation of antidepressant treatment in patients with major depressive disorder. Korean J Psychopharmacol 2006;17:550-556.
  19. Kim NS, Kim KH, Lee SM, Paik JW, Lee BR, Hwang JH. Health services utilization and depression care quality among depressed patients. Seoul: Health insurance review and assessment service;2008.
  20. Keith SJ, Kane JM. Partial compliance and patient consequences in schizophrenia: our patients can do better. J Clin Psychiatry 2003;64:1308-1315. https://doi.org/10.4088/JCP.v64n1105
  21. Haynes R, Taylor D, Sackett D. Compliance in Health Care. baltimore: Johns Hopkins University Press;1979.
  22. Frank E, Perel JM, Mallinger AG, Thase ME, Kupfer DJ. Relationship of pharmacologic compliance to longterm prophylaxis in recurrent depression. Psychopharmacol Bull 1992;28:231-235
  23. Byrne N, Regan C, Livingston G. Adherence to treatment in mood disorders. Curr Opin Psychiatry 2006;19:44-49. https://doi.org/10.1097/01.yco.0000191501.54034.7c
  24. George CF, Peveler RC, Heiliger S, Thompson C. Compliance with tricyclic antidepressants: the value of four different methods of assessment. Br J Clin Pharmacol 2000;50:166-171. https://doi.org/10.1046/j.1365-2125.2000.00244.x
  25. Kruse W, Weber E. Dynamics of drug regimen compliance-its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990;38:561-565. https://doi.org/10.1007/BF00278582
  26. Demyttenaere K, Enzlin P, Dewe W, Boulanger B, De Bie J, De Troyer W, et al. Compliance with antidepressants in a primary care setting, 1: Beyond lack of efficacy and adverse events. J Clin Psychiatry 2001;62:30-33. https://doi.org/10.4088/JCP.v62n0107
  27. Kim JB. A Cognitive Therapy Approach to Enhance Medication Compliance(in Korean). J Korean Society of Biological Therapies in Psychiatry 2002;8:34-39.
  28. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care 1986;24:67-74 https://doi.org/10.1097/00005650-198601000-00007
  29. Kim SW, Kim MY, Yoo TW, Huh BR. Concurrent validity of the Korean version of self-reported questionnaire (in Korean). J Korean Acad Fam Med 1995;16:172-180.
  30. Byerly M, Fisher R, Whatley K, Holland R, Varghese F, Carmody T, et al. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res 2005;133:129-133. https://doi.org/10.1016/j.psychres.2004.11.002
  31. Kemp R, Hayward P, Applewhaite G, Everitt B, David A. Compliance therapy in psychotic patients: randomised controlled trial. BMJ 1996;312:345-349. https://doi.org/10.1136/bmj.312.7027.345
  32. Park MC. Psychodynamic Approach for Adherence(in Korean). J Korean Society of Biological Therapies in Psychiatry 2002;8:40-45.
  33. Tasman A, Riba MB, Silk KR. The doctor-patient relationship in pharmacotherapy: improving treatment effectiveness. New York: The Guilford Press;2000.
  34. Fawcett J. Compliance: definitions and key issues. J Clin Psychiatry 1995;56:4-8.
  35. Kaplan EM. Antidepressant noncompliance as a factor in the discontinuation syndrome. J Clin Psychiatry 1997;58:31-35.
  36. Blackwell B. Treatment adherence. Br J Psychiatry 1976;129:513-531. https://doi.org/10.1192/bjp.129.6.513
  37. Sirey JA, Bruce ML, Alexopoulos GS, Perlick DA, Friedman SJ, Meyers BS. Stigma as a barrier to recovery: Perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatr Serv 2001;52:1615-1620. https://doi.org/10.1176/appi.ps.52.12.1615
  38. Judge R. Patient perspectives on once-weekly fluoxetine. J Clin Psychiatry 2001;62:53-57.
  39. de Craen AJ, Roos PJ, Leonard de Vries A, Kleijnen J. Effect of colour of drugs: systematic review of perceived effect of drugs and of their effectiveness. BMJ 1996;313:1624-1626. https://doi.org/10.1136/bmj.313.7072.1624
  40. Buckalew LW, Coffield KE. An investigation of drug expectancy as a function of capsule color and size and preparation form. J Clin Psychopharmacol 1982;2:245-248.
  41. Boyle E, Chambers M. Medication compliance in older individuals with depression: gaining the views of family carers. J Psychiatr Ment Health Nurs 2000;7:515-522. https://doi.org/10.1046/j.1365-2850.2000.00356.x
  42. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990;150:841-845. https://doi.org/10.1001/archinte.150.4.841
  43. Cohen NL, Ross EC, Bagby RM, Farvolden P, Kennedy SH. The 5-factor model of personality and antidepressant medication compliance. Can J Psychiatry 2004;49:106-113 https://doi.org/10.1177/070674370404900205
  44. Ekselius L, Bengtsson F, von Knorring L. Non-compliance with pharmacotherapy of depression is associated with a sensation seeking personality. Int Clin Psychopharmacol 2000;15:273-278. https://doi.org/10.1097/00004850-200015050-00004
  45. Book HE. Some psychodynamics of non-compliance. Can J Psychiatry 1987;32:115-117. https://doi.org/10.1177/070674378703200207
  46. DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, et al. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol 1993;12:93-102. https://doi.org/10.1037/0278-6133.12.2.93
  47. Frank E, Kupfer DJ, Siegel LR. Alliance not compliance: a philosophy of outpatient care. J Clin Psychiatry 1995;56:11-16.
  48. Katon W, Von Korff M, Lin E, Walker E, Simon GE, Bush T, et al. Collaborative management to achieve treatment guidelines. Impact on depression in primary care. JAMA 1995;273:1026-1031. https://doi.org/10.1001/jama.273.13.1026
  49. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry 1996;53:924-932. https://doi.org/10.1001/archpsyc.1996.01830100072009
  50. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002;288:2868-2879. https://doi.org/10.1001/jama.288.22.2868
  51. Peveler R, George C, Kinmonth AL, Campbell M, Thompson C. Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial. BMJ 1999;319:612-615. https://doi.org/10.1136/bmj.319.7210.612
  52. Bollini P, Pampallona S, Kupelnick B, Tibaldi G, Munizza C. Improving compliance in depression: a systematic review of narrative reviews. J Clin Pharm Ther 2006;31:253-260. https://doi.org/10.1111/j.1365-2710.2006.00733.x